Hormone delivery system and method

1. A pre-packaged hormone delivery system comprising:

a pre-packaged, predetermined quantity of bio-identical progesterone, wherein said bio-identical progesterone is provided in a modality selected from the list comprising: a transdermal application; and an oral modality;

a pre-packaged, predetermined quantity of indole provided sequentially in a 400 mg dosage in a modality selected from the list comprising: a transdermal application; and an oral modality;

said bio-identical progesterone delivered to a patient in predetermined doses during a predetermined cycle; and

said bio-identical progesterone configured to treat a menstrual disorder.

2. The pre-packaged hormone delivery system of claim 1 , wherein said predetermined cycle is a 25-day cycle, and wherein said menstrual disorder is selected from the list comprising: premenstrual syndrome; and menstrual cramp dysmenorrhea.

3. The pre-packaged hormone delivery system of claim 1 , further comprising:

a pre-packaged, predetermined quantity of bio-identical estrogen, wherein said bio-identical estrogen is provided in a modality selected from the list comprising:

an oral pill; a sublingual pill; a patch; or a gel;

wherein said bio-identical estrogen is delivered sequentially with said bio-identical progesterone; and

wherein said estrogen and said progesterone are contained in separate modalities.

4. The pre-packaged hormone delivery system of claim 3 , further comprising:

wherein said estrogen is provided in a thirty-day cycle and is packaged accordingly within said pre-packaged delivery system;

wherein said progesterone is packaged such that it is introduced between days ten and fifteen of said thirty-day cycle.

5. The pre-packaged hormone delivery system of claim 3 , further comprising:

wherein said progesterone is provided in a thirty-day cycle and is packaged accordingly within said pre-packaged delivery system; and

wherein said estrogen is packaged such that it is introduced between days ten and fifteen of said thirty-day cycle.

6. The pre-packaged hormone delivery system of claim 3 , wherein said bio-identical progesterone is derived from plants.

7. The pre-packaged hormone delivery system of claim 3 , wherein said bio-identical estrogen is derived from plants.

8. The pre-packaged hormone delivery system of claim 3 , wherein said menstrual disorder is associated with perimenopause, menopause, and post-menopause.

9. The pre-packaged hormone delivery system of claim 3 , wherein said menstrual disorder is polycystic ovary syndrome.

10. The pre-packaged hormone delivery system of claim 3 , wherein said bio-identical progesterone is delivered in a dosage amount selected from the list comprising: 0.025 mg; 0.0375 mg; 0.05 mg; 0.075 mg; 0.25 mg; 0.375 mg; 0.75 mg; and 1.0 mg.

11. The pre-packaged hormone delivery system of claim 1 , further comprising:

wherein said bio-identical progesterone is delivered in a dosage amount selected from the list comprising: 20 mg; 30 mg; 50 mg; 100 mg; 200 mg; and 300 mg; and

wherein said menstrual disorder comprises insomnia symptoms.

12. The pre-packaged hormone delivery system of claim 3 , wherein said bio-identical estrogen is delivered in a dosage amount selected from the list comprising: 0.025 mg; 0.0375 mg; 0.05 mg; 0.075 mg; and 0.1 mg.

13. The pre-packaged hormone delivery system of claim 1 , wherein said indole is selected from the list of indoles comprising: Di-indole methane and 3-indole carbinol.

14. The pre-packaged hormone delivery system of claim 3 , further comprising:

a pre-packaged, predetermined quantity of bio-identical testosterone, wherein said bio-identical testosterone is provided in a modality selected from the list comprising:

transdermally; and intramuscularly;

wherein said bio-identical testosterone is delivered sequentially with said bio-identical progesterone and said bio-identical estrogen; and

wherein said bio-identical testosterone is provided from day 7 through day 20 of a 28-day cycle.

15. The system of claim 13 , further comprising:

wherein said indole is applied in combination with the progesterone only during days 10-31 of each cycle; and

wherein the daily dosages of said indole are selected from a list of dosages comprising:

100 mg; 200 mg; and 400 mg.

16. The system of claim 13 , wherein said indole is applied daily throughout the entire cycle and wherein said daily dosages of said indole are selected from a list of dosages comprising: 100 mg; 200 mg; and 400 mg.